These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Losartan as disease modulating therapy for recessive dystrophic epidermolysis bullosa. Author: Inamadar AC. Journal: Dermatol Ther; 2020 Nov; 33(6):e14279. PubMed ID: 32888385. Abstract: A 6-year-old child with recessive dystrophic epidermolysis bullosa, confirmed by history, clinical exam, and antigen mapping, was treated with losartan with reduction in the blistering and better quality of life.[Abstract] [Full Text] [Related] [New Search]